Mesoblast (MEOBF) Income from Continuing Operations (2014 - 2023)

Mesoblast has disclosed Income from Continuing Operations across 10 years of filings, most recently posting -$21.6 million for Q2 2023.

• In Q2 2023, Income from Continuing Operations fell 113.31% year-over-year to -$21.6 million; the TTM figure through Jun 2023 stood at -$81.9 million (down 189.18% YoY), while the FY2026 annual figure was $56.3 million, down 44.55% from the prior year.
• Income from Continuing Operations came in at -$21.6 million for Q2 2023 at Mesoblast, down from -$18.7 million in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of $178.7 million in Q2 2021 to a low of -$57.6 million in Q1 2020.
• Average Income from Continuing Operations over 5 years is -$3.0 million, with a median of -$24.6 million recorded in 2022.
• Year-over-year, Income from Continuing Operations soared 55.32% in 2019 and tumbled 178.18% in 2020.
• Over 5 years, Income from Continuing Operations stood at -$38.5 million in 2019, then jumped by 33.6% to -$25.5 million in 2020, then declined by 2.2% to -$26.1 million in 2021, then advanced by 5.66% to -$24.6 million in 2022, then increased by 12.4% to -$21.6 million in 2023.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were -$21.6 million in Q2 2023, -$18.7 million in Q1 2023, and -$24.6 million in Q4 2022.